Upper GI 2017

 PS 0–1 compared with PS 2 and locally advanced disease compared with metastatic disease were significant predictors of improved OS  Progression of disease during first-line treatment or within the first 3 months of completion of first-line treatment were predictors of an increased risk of death compared with progression between 3 and 6 months

03/28/2017